Raymond James raises Fulgent Genetics stock price target to $36 on strong performance
Director Donald A. Colvin of Viavi Solutions Inc (NASDAQ:VIAV) sold 39,900 shares of common stock on November 4, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sale comes as Viavi’s stock has demonstrated remarkable momentum, surging nearly 20% in the past week and trading near its 52-week high of $17.99.
The sales were executed in two tranches. The first sale involved 23,050 shares at a price of $16.98, with prices ranging from $16.97 to $17.03 for a total value of $391,489. The second sale was for 16,950 shares at $17.24, for a total value of $292,118. The total value of shares sold amounts to $683,607. InvestingPro data indicates the stock is currently trading at a P/E ratio of 287, suggesting a premium valuation, with technical indicators pointing to overbought territory.
Following the transactions, Colvin directly owns 148,524 shares of Viavi Solutions Inc. The timing of the sale aligns with Viavi’s impressive 85.6% price return over the past six months. InvestingPro offers 17 additional insights on Viavi Solutions, including detailed Fair Value analysis and comprehensive Pro Research Reports that transform complex data into actionable intelligence for smarter investing decisions.
In other recent news, Viavi Solutions reported impressive fiscal first-quarter 2026 results, with revenue reaching $299 million, marking a 25.6% increase from the previous year. This figure surpassed both management guidance and analyst consensus estimates of $294 million. The Network and Service Enablement segment was a significant contributor, generating $216 million in revenue, driven by demand in the data center ecosystem. Viavi’s earnings per share also exceeded expectations, coming in at $0.15 compared to the anticipated $0.13. Following these strong results, Stifel raised its price target for Viavi Solutions to $18 while maintaining a Buy rating. Additionally, B.Riley upgraded the company’s stock from Neutral to Buy, highlighting growth opportunities in artificial intelligence and data centers. Viavi’s recent acquisition of Inertial Labs also played a role in its revenue growth. The company’s non-GAAP operating margin improved to 15.7%, up 570 basis points from the previous year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.